Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
10%
Ph phase_4
6
60%
Ph phase_1
1
10%
Ph not_applicable
1
10%

Phase Distribution

1

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
6(66.7%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(5)
Other(3)

Detailed Status

Completed5
unknown3
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 46 (66.7%)
N/A1 (11.1%)

Trials by Status

not_yet_recruiting110%
completed550%
unknown330%
recruiting110%

Recent Activity

1 active trials
Showing 5 of 10
recruitingphase_4

Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

NCT07314281
not_yet_recruitingnot_applicable

Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.

NCT06818565
unknownphase_4

Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection

NCT05393505
completedphase_1

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

NCT04555798
completedphase_4

Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy

NCT04370145
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07314281Phase 4

Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

Recruiting
NCT06818565Not Applicable

Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.

Not Yet Recruiting
NCT05393505Phase 4

Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection

Unknown
NCT04555798Phase 1

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

Completed
NCT04370145Phase 4

Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy

Completed
NCT04629378Phase 2

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB

Completed
NCT04154722Phase 4

Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children

Completed
NCT04671589Phase 4

Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic.

Unknown
NCT03645668Phase 4

Efficacy and Pharmacokinetics of Meropenem in Severe Septic Patients

Completed
NCT03571711

Meropenem Pharmacokinetics in Spontaneous Bacterial Peritonitis

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10